OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Infection and Chemotherapy is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Development of toluidine red particle agglutination-based turbidimetric immunoassay for anticardiolipin antibody detection in syphilis	807416368
Antimicrobial photodynamic effect of the photosensitizer riboflavin, alone and in combination with colistin, against pandrug-resistant Pseudomonas aeruginosa clinical isolates	540160058
Therapeutic potential of ciclesonide inhalation for COVID-19 pneumonia: Report of three cases	93
Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient	70
Comparative evaluation of nasopharyngeal swab and saliva specimens for the molecular detection of SARS-CoV-2 RNA in Japanese patients with COVID-19	61
National trend of blood-stream infection attributable deaths caused by Staphylococcus aureus and Escherichia coli in Japan	58
The evaluation of a newly developed antigen test (QuickNavi™-COVID19 Ag) for SARS-CoV-2: A prospective observational study in Japan	40
Clinical course of 2019 novel coronavirus disease (COVID-19) in individuals present during the outbreak on the Diamond Princess cruise ship	38
Clinical validation of quantitative SARS-CoV-2 antigen assays to estimate SARS-CoV-2 viral loads in nasopharyngeal swabs	37
Surveillance in hospitalized children with infectious diseases in Japan: Pre- and post-coronavirus disease 2019	36
Ventilator-associated bacterial pneumonia in coronavirus 2019 disease, a retrospective monocentric cohort study	36
Suspected cholestatic liver injury induced by favipiravir in a patient with COVID-19	36
Reactogenicity following two doses of the BNT162b2 mRNA COVID-19 vaccine: Real-world evidence from healthcare workers in Japan	33
Analysis of a persistent viral shedding patient infected with SARS-CoV-2 by RT-qPCR, FilmArray Respiratory Panel v2.1, and antigen detection	33
Clinical characteristics of COVID-19 in hospitalized children during the Omicron variant predominant period	33
Adverse reactions to the BNT162b2 and mRNA-1273 mRNA COVID-19 vaccines in Japan	31
SARS-CoV-2 detection by fluorescence loop-mediated isothermal amplification with and without RNA extraction	31
Post COVID-19 condition of the Omicron variant of SARS-CoV-2	31
Distribution of Legionella species and serogroups in patients with culture-confirmed Legionella pneumonia	30
Mycobacterium chimaera infections: An update	30
COVID-19 vaccine induced interstitial lung disease	29
Immunochromatography and chemiluminescent enzyme immunoassay for COVID-19 diagnosis	28
Single-dose oral ivermectin in mild and moderate COVID-19 (RIVET-COV): A single-centre randomized, placebo-controlled trial	27
Comparison of COVID-19 disease between young and elderly patients: Hidden viral shedding of COVID-19	27
Evaluating a novel, highly sensitive, and quantitative reagent for detecting SARS-CoV-2 antigen	27

Evaluation of clinical utility of novel coronavirus antigen detection reagent, Espline® SARS-CoV-2